The Wize Mirror will use an array of sensors to detect changes in an individual's face and breath that point to the onset of diabetes, a heart attack or other cardiovascular diseases.
The Wize Mirror, being developed by Semeoticons, a research group backed by the European Commission, then provides a health score and suggest lifestyle changes.
A multispectral imaging system, which uses five cameras to capture specific wavelengths of light and a skin heater to stimulate the face, analyses tissue for fat content and blood for haemoglobin levels.
The Wize Sniffer captures breath samples to detect toxic molecules that suggest the use of tobacco and alcohol. The whole process takes about a minute.
Clinical trials of the Wize Mirror are expected to begin next year in Italy and France.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
